923 results about "Porous particle" patented technology

Echogenic devices, and methods of making and using such devices, are disclosed. In one aspect, the devices include a porous polymeric material that is preparable by extracting a phase separated composition. In another aspect, the echogenic devices include a polymeric composition having porous particles therein. Preferably the devices are medical devices.

Porous particles comprising a polymer binder and at least one additive distinct from any pore stabilizing compound present in the particle, wherein: the polymer binder comprises a solid compositionally continuous phase having an external particle surface; discrete pores are dispersed within the solid compositionally continuous phase, forming internal pore surfaces; and the at least one additive is present primarily in the discrete pores. The additive may further preferably not be present in the solid compositionally continuous phase, and be substantially absent from the external particle surface. A toner set for forming a color electrophotographic image comprising a plurality of different colored toners, where at least one of the different colored toners comprise such porous particles comprising additives, and in a particular embodiment wherein at least two different colored toners each comprise different pigments present primarily in the internal pores. A process of making such porous particles.

The present invention is toner particle that includes a continuous phase of binder polymer and a second phase of hydrocolloid. The particle has a porosity of at least 10 percent.

Methods and devices are provided for reducing the concentration of low molecular weight compounds in a biological composition, while substantially maintaining a desired biological activity of the biological composition. The device comprises highly porous adsorbent particles, and the adsorbent particles are immobilized by an inert matrix. The matrix containing the particles is contained in a housing, and the particles range in diameter from about 1 μm to about 200 μm. The matrix can be fibrous, and the particles can have a surface area greater than 750 m2 / g and a pore diameter between about 25 and 800 Å. The device can be used to adsorb and remove a pathogen-inactivating compound that is a nucleic acid-binding compound such as psoralen, an acridine derivative or a dye from a biological composition such as a blood product.